Role of Surgical Pathologist for Detection of Predictive Immuno-oncological Factors in Breast Cancer
{{output}}
Immune checkpoint inhibitors (ICIs) have changed therapy strategies in breast cancer (BC) patients suffering from triple-negative breast cancer (TNBC). For example, in Europe the anti-programmed cell death 1 ligand 1 (PD-L1) ICI Azetolizumab is approved for ad... ...
